Once a drug’s patent has expired, it does not mean the end of its profitability. After all, there are a number of strategies – from maintaining brand equity to launching your own generic alternative – that could still lead to a significant amount of revenue.
That said, doing so requires a good amount of insight and planning, including surveying the market and completing competitive simulations.
Many see compendia databases as just a pricebook, but they’re so much more. In fact, an incorrect classification can mean a failed launch.
Just as with launching a new product, managing a product’s loss of exclusivity (LOE) requires strategic planning and oversight.
Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.
Our extensive experience monitoring and assessing all therapeutic categories allows us to provide insights to support licensing and acquisition decisions.
Whether your drug is going off-patent soon or you are developing a new agent, gaining insight into other generics and biosimilars in development is critical.
